My interest and expertise in immunotherapy started in early 1990s with animal models of IL - 2 and IL - 15 cytokines and natural
killer cell development, continued with high dose IL - 2 studies and subsequently Phase I - III trials with both CTLA - 4 and PD1 / PDL -1 checkpoint inhibitors.
Not exact matches
In December, SQZ partnered with global pharma firm and cancer treatment leader F. Hoffmann - La Roche in a deal that could be worth $ 500 million or more — a large undisclosed upfront payment, and additional sums when SQZ meets certain milestones — to speed up the
development of its technology specifically to inject a person's immune
cells with a protein to activate a «
killer T»
cell response to fight off cancer.
Prof. Mandelboim and his research collaborators found that the NKp46 receptor present on Natural
Killer or NK
cells (an essential part of the immune system) play a critical role in the
development of the disease in mice.
This biosynthetic hybrid stimulates the
development of weak T regs into
killer T
cells that destroy the immune
cells directing the autoimmune attack.
Natural
killer cells serve important roles in clearing non-type 2 inflammatory
cells, so identification of a defect in NK
cell function in severe asthma provides a window for the
development of new therapeutic approaches.
Another interesting finding was the impact of the antibody on CD4 + T
cells, helper
cells that promote the
development of
killer T
cells called CD8 +, which target and destroy virus - infected liver
cells.
One of these T
cell subsets is comprised of the CD1d - reactive invariant natural
killer T
cells, and over the years we have studied the
development, homeostasis, activation and regulation of function of these
cells, as well as their specificity and the pathways leading to the processing and presentation of antigens by CD1d.
Requirement for IRF - 1 in the microenvironment supporting
development of natural
killer cells.
«This is an exciting finding because it could possibly lead to the
development of drugs that improve Natural
Killer cell function,» said TSRI Associate Professor Karsten Sauer, who led the study.
They found that these
killer T -
cells are highly «cross-reactive», and respond to a variety of pathogen - derived antigens, which could lead to the breaking of self - tolerance and to the
development of autoimmune disease, such as type 1 diabetes.
This finding sheds new light on how these
killer T -
cells are turned into rogues, leading to the
development of type 1 diabetes.»
Ben - Eliyahu S, Page GG, Yirmiya R, et al: Evidence that stress and surgical interventions promote tumor
development by suppressing natural
killer cell activity.